Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Schizophrenia

Free Subscription 02.09.2024 1 Acta Psychiatr Scand 2 Biol Psychiatry 2 J Clin Psychiatry 1 J Nerv Ment Dis 1 J Psychiatry Neurosci 1 Mol Psychiatry 3 Psychiatry Res 15 Schizophr Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Psychiatr Scand

1. KEINANEN J, Eskelinen S, From T, Laurikainen H, et al
   Psychosis metabolic risk calculator (PsyMetRiC) in early psychosis: External validation study in Finland.
   Acta Psychiatr Scand. 2024 Aug 29. doi: 10.1111/acps.13752.
   PubMed         Abstract available
   
   

   
   Biol Psychiatry

2. SCHLEIFER CH, Chang SE, Amir CM, O'Hora KP, et al
   Unique functional neuroimaging signatures of genetic versus clinical high risk for psychosis.
   Biol Psychiatry. 2024 Aug 22:S0006-3223(24)01538.
   PubMed         Abstract available
   
   
3. LIDDLE PF, Sami MB
   The mechanisms of persisting disability in schizophrenia: imprecise predictive coding via cortico-striatal-thalamo-cortical loop dysfunction.
   Biol Psychiatry. 2024 Aug 22:S0006-3223(24)01535.
   PubMed         Abstract available
   
   

   
   J Clin Psychiatry

4. CORRELL CU, Xiang P, Sarikonda K, Bhagvandas N, et al
   The Economic Impact of Cognitive Impairment and Negative Symptoms in Schizophrenia: A Targeted Literature Review With a Focus on Outcomes Relevant to Health Care Decision-Makers in the United States.
   J Clin Psychiatry. 2024;85:24r15316.
   PubMed         Abstract available
   
   
5. KINON BJ, Leucht S, Tamminga C, Breier A, et al
   Rationale for Adjunctive Treatment Targeting Multiple Mechanisms in Schizophrenia.
   J Clin Psychiatry. 2024;85:23nr15240.
   PubMed         Abstract available
   
   

   
   J Nerv Ment Dis

6. RICCI V, Maina G, Di Petta G, Martinotti G, et al
   The Resurgence of Exogenous Psychosis: A Phenomenological Examination of Substance-Induced Psychopathology.
   J Nerv Ment Dis. 2024;212:457-459.
   PubMed         Abstract available
   
   

   
   J Psychiatry Neurosci

7. WANG Z, Wu T, Hu H, Alabed AAA, et al
   Plasma exosomes carrying mmu-miR-146a-5p and Notch signalling pathway-mediated synaptic activity in schizophrenia.
   J Psychiatry Neurosci. 2024;49:E265-E281.
   PubMed         Abstract available
   
   

   
   Mol Psychiatry

8. KAMBALI M, Li Y, Unichenko P, Feria Pliego JA, et al
   An increased copy number of glycine decarboxylase (GLDC) associated with psychosis reduces extracellular glycine and impairs NMDA receptor function.
   Mol Psychiatry. 2024 Aug 30. doi: 10.1038/s41380-024-02711.
   PubMed         Abstract available
   
   

   
   Psychiatry Res

9. MORO L, Sicotte R, Joober R, Malla A, et al
   Trajectories of suicidality during a 2-year early-intervention program for first-episode psychosis: A longitudinal study.
   Psychiatry Res. 2024;340:116148.
   PubMed         Abstract available
   
   
10. GUZMAN A, Klein H, Keefe RS, Horan WP, et al
    Location-based differences in cognition and functional capacity: Consistent levels of impairment in participants with schizophrenia compared to healthy controls.
    Psychiatry Res. 2024;340:116121.
    PubMed         Abstract available
    
    
11. COHEN S, Goldsmith DR, Ning CS, Addington J, et al
    Sleep disturbance, suicidal ideation and psychosis-risk symptoms in individuals at clinical high risk for psychosis.
    Psychiatry Res. 2024;341:116147.
    PubMed         Abstract available
    
    

    
    Schizophr Res

12. FOERSTER FR, Joos E, Martin B, Coull JT, et al
    Self and time in individuals with schizophrenia: A motor component?
    Schizophr Res. 2024;272:12-19.
    PubMed         Abstract available
    
    
13. GU B, Rose J, Kurtz MM
    Cognitive training for schizophrenia: Do race and ethnicity matter?
    Schizophr Res. 2024;272:20-25.
    PubMed         Abstract available
    
    
14. POLETTI M, Raballo A
    Ontogenesis of self-disorders in the schizophrenia spectrum: A phenomenological neuro-developmental model.
    Schizophr Res. 2024;272:26-35.
    PubMed         Abstract available
    
    
15. REDLICH BOSSY M, Muller DR, Jabat M, Burrer A, et al
    Relationship between psychopathological symptoms and dimensions in inpatients with schizophrenia: A network analysis.
    Schizophr Res. 2024;272:36-38.
    PubMed        
    
    
16. LIU Z, Sun YH, Ren Y, Perez JM, et al
    Upregulated solute-carrier family genes in the hippocampus of schizophrenia can be rescued by antipsychotic medications.
    Schizophr Res. 2024;272:39-50.
    PubMed         Abstract available
    
    
17. JIMENEZ AM, Green MF
    Disturbance at the self-other boundary in schizophrenia: Linking phenomenology to clinical neuroscience.
    Schizophr Res. 2024;272:51-60.
    PubMed         Abstract available
    
    
18. TARGUM SD, Ge T, Asgharnejad M, Reksoprodjo P, et al
    Use of video-recordings of site-based interviews for quality assurance in a study of subjects with schizophrenia and persistent negative symptoms.
    Schizophr Res. 2024;272:61-68.
    PubMed         Abstract available
    
    
19. SHIRINBAKHSHMASOLEH M, Aboulatta L, Leong C, Riel H, et al
    The impact of COVID-19 public health measures on the utilization of antipsychotics in schizophrenia in Manitoba - A population-based study.
    Schizophr Res. 2024;272:69-76.
    PubMed         Abstract available
    
    
20. MARKOTA M, Croarkin PE, Coombes BJ, Gentry MT, et al
    Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia.
    Schizophr Res. 2024;272:77-78.
    PubMed        
    
    
21. COTTER SJ, Smith CL, Gao CX, Khanna R, et al
    What impact did the COVID-19 pandemic have on psychosis and the delivery of early intervention psychosis services?
    Schizophr Res. 2024;272:79-88.
    PubMed         Abstract available
    
    
22. MLAKAR V, Akkouh I, Halff EF, Srivastava DP, et al
    Telomere biology and its maintenance in schizophrenia spectrum disorders: Exploring links to cognition.
    Schizophr Res. 2024;272:89-95.
    PubMed         Abstract available
    
    
23. SONG SH, Hayirli TC, Shore O, Coconcea C, et al
    Atypical presentation of schizophrenia with ablution avoidance: A case report.
    Schizophr Res. 2024;272:96-97.
    PubMed        
    
    
24. LIZANO P, Karmacharya R
    Harnessing stem cell-based approaches for clinically meaningful discoveries in schizophrenia.
    Schizophr Res. 2024 Aug 29:S0920-9964(24)00377.
    PubMed        
    
    
25. ELKIS H, Melzer-Ribeiro DL, Napolitano IC
    Response to Markota et al. "Clinical heterogeneity and ECT in patients with clozapine resistant schizophrenia" SCHRES-D-24-00481.
    Schizophr Res. 2024;272:110-111.
    PubMed        
    
    
26. REAVIS EA, Wynn JK, Green MF
    Pre-stimulus EEG phase coherence predicts visual target detection failures in schizophrenia: A pilot study.
    Schizophr Res. 2024;272:112-119.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.